The Singapore Registrant: Legal Holder of the Registration

1. Key takeaways

The Registrant is the Singapore-based entity that submits the registration application to HSA and obtains the registration; it is the holder of the registration certificate. HSA does not accept applications filed directly by foreign manufacturers; the foreign Product Owner must authorise a Singapore-registered company to act as its Registrant using the Letter of Authorisation (LoA) template in Annex 1 of GN-15. The authorisation remains valid continuously from the moment of signature, until the Product Owner notifies HSA in writing of its revocation. This makes the choice of Registrant a structural decision rather than an administrative one: the entity you appoint controls the application, the dialogue with the regulator and the ongoing legal standing of your products in Singapore.

• Only a Singapore local entity can be a Registrant; foreign manufacturers must appoint one through the GN-15 Annex 1 LoA.
• The Registrant is the legal holder of the certificate and the counterpart for all formal dealings with HSA.
• Obligations run through the whole life cycle: pre-submission preparation, responding to technical queries, annual retention fees, change notifications, AE/FSCA reporting and change of registrant.
• Registrant status and dealer licensing are separable; only when the Registrant itself imports or wholesales does it also need the corresponding licence.

2. Legal basis

The instruments governing the Registrant role cover the authorisation instrument itself, the public listing of the parties, and the procedure for changing the Registrant during the life of a certificate.

These elements together define who may hold a certificate and how control of it moves between entities. Because the LoA follows a prescribed template and the change-of-registrant procedure requires cooperation between the outgoing and incoming parties, the contractual arrangements you put in place at the start of the relationship largely determine how much leverage you have at the end of it.

3. Expert insights

Insight 1: The Singapore Registrant is not the equivalent of the EU EC Rep or the UK RP. This is the most common conceptual migration error among Chinese manufacturers. Under the EU system, the authorised representative (EC Rep) primarily performs liaison and document custodian functions, with the marketing authorisation remaining deeply tied to the manufacturer; in Singapore, by contrast, the Registrant is the legal holder of the registration certificate and its applicant, and all formal dealings with HSA proceed in its name. Treating the role as a mailing address will cost you in change procedures, renewals and enforcement situations. A Registrant that receives a deficiency letter can choose how quickly to relay it; a Registrant approached by an inspector controls the immediate narrative; and a Registrant that stops cooperating can freeze your ability to manage the certificate at all.

Insight 2: The Registrant’s obligations run through the whole life cycle; they do not end once the submission is filed. The obligation list we give clients is structured by stage:

Seen this way, the appointment of a Registrant is the opening of a multi-year relationship with defined duties at every stage, not a one-off filing service. Budgets, contracts and internal ownership must reflect that reality.

Insight 3: Registrant qualification and the Dealer’s Licence are two separate matters. An entity can be a Registrant without importing (importation being performed by a separately licensed importer); conversely, holding a dealer licence does not automatically make an entity a Registrant. Only when the Registrant itself also imports or wholesales does it need to hold the corresponding Dealer’s Licence as well. This separability is the key to designing the entity architecture (see Chapters 33 and 40 for detail): it allows a company to separate the legal anchor of the certificate from the logistics and distribution functions, and to select different partners for each role where that serves the business better.

Insight 4: The Registrant can be replaced, but it requires cooperation from both sides. Under GN-24 R2, a change of Registrant requires the cooperation of the outgoing and the incoming Registrant; the official fee is S$880 and the review period is 40 working days. If the outgoing Registrant happens to be your distributor and refuses to cooperate, the cost of switching rises sharply — which is why we require clients to agree exit clauses in advance during contract review. A clause covering data handover, signatory obligations during the transition window and cost allocation turns a potential deadlock into a managed process.

4. Practical recommendations

• Select the Registrant as the legal anchor for the Singapore market, not as a logistics or customs clearance service provider.
• Check SMDR before signing: look at how many certificates the candidate Registrant actually holds, which product categories they cover, and which manufacturers it has worked with.
• The contract must cover six items: access to technical documentation, response deadlines for HSA queries, cost allocation (including the annual retention fee), timelines for relaying AE information, change and exit mechanisms, and confidentiality.
• Fix who answers technical queries: the review clock stops while HSA waits for a response, so the speed of response directly determines the actual time to market.

5. Verification checklist

• □ It has been confirmed that HSA does not accept direct submissions from foreign entities
• □ The Singapore Registrant entity has been determined and its local registration status verified
• □ The LoA has been signed using the GN-15 Annex 1 template
• □ The Registrant’s certificate-holding record in SMDR has been reviewed
• □ The contract between Registrant and Product Owner covers the six key clauses
• □ The responsible party and timeline for answering HSA technical queries have been fixed

Regulatory information verified as of: 26 October 2026

Source level: Tier 2 (GN-15 R15 and Annex 1, GN-24 R2), Tier 3 (industry compilation of HSA fee page information, subject to the official website)

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Singapore. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with HSA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com